Pyxis Oncology to Acquire Apexigen for US$16 M
By Ayush Saxena
Pharma Deals Review: Vol 2023 Issue 6 (Table of Contents)
Published: 14 Jun-2023
DOI: 10.3833/pdr.v2023.i6.2791 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its oncology portfolio, Pyxis Oncology has entered into a definite agreement to acquire Apexigen in an all-stock deal for a total value of US$16 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS